Organoids are miniature versions of human organs that are advancing the study of biology and medicine. These three dimensional, simplified structures can provide an excellent research model, and in ...

October 20, 2009 — Researchers have come a little bit closer to understanding the biology of urothelial cell carcinoma (UCC), the most common form of bladder cancer. According to preliminary data ...

Urinary tract infections are among the most common bacterial infections worldwide, but for many people they are not a ...

LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS today presented a late-breaking poster titled “Significant cytotoxic and immunomodulatory effects of continuous low-dose intravesical gemcitabine in rodent ...

NEW YORK, NY – August 17, 2010 – The Urothelial Biology Team at NYU School of Medicine received an $8.2 million, five-year program project (P01) grant from the National Institute of Diabetes and ...

Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. This is an ASCO Meeting Abstract from the 2019 Genitourinary ...

The Johns Hopkins Greenberg Bladder Cancer Institute awarded research grants to four projects that focus on understanding how treatment of bladder cancer affects women, why the disease has a less ...

A collaborative study, which includes contributions from NDORMS researchers Adam Crowther and supervisor Dario Carugo, explores new ways to model bladder biology. Urinary tract infections (UTIs) ...

Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...

BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer immunotherapy. Now, ...